As a member of the Community Care Program, Dr. McNeer sees patients in the southwest suburbs and in northwest Indiana, making care accessible to patients and families in these locations and building strong relationships with their primary care physicians.
In addition to caring for patients, Dr. McNeer is a clinical researcher, focusing on improving treatment strategies for high-risk leukemia patients. She holds a master's degree in clinical investigation.
Areas of Expertise
Board Certifications
- Pediatrics
- Pediatric Hematology and Oncology
Memberships & Medical Societies
- American Society of Hematology
- Alpha Omega Alpha Honor Medical Society
- Children’s Oncology Group
Practicing Since
- 2009
Languages Spoken
- English
Medical Education
- New York Medical College
Internship
- Ann and Robert H. Lurie Children's Hospital
Residency
- Ann and Robert H. Lurie Children's Hospital of Chicago
Fellowship
- Ann and Robert H. Lurie Children's Hospital of Chicago
Other Grad Education
- MS, Northwestern University
News & Research
View Published Papers- Matched Targeted Therapy For High-Risk Leukemias and MDS
- A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
- CLINICAL TRIAL / IRB18-0473
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
- Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
- Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Testicular Tissue Cryopreservation for Fertility Preservation
- Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
- Aetna HMO (specialists only)
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Aetna Better Health *see insurance page
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- Aetna Medicare Advantage HMO & PPO
- BCBS Medicare Advantage HMO & PPO
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- United Choice HMO (specialists only)
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.
Comer Children's Hospital - Hyde Park
Request an Appointment at Comer Children's Hospital - Hyde Park
Comer Children's at Edward Hospital - Naperville
Request an Appointment at Comer Children's at Edward Hospital - Naperville
To Refer a Patient
Refer a Patient